Author

Christian Ploner

Innsbruck Medical UniversityORCID 0000-0002-0313-2960Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 2 Approach:experimental assay· 2 Organism:human· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Assay:imaging· 1

Frequent Co-Authors

Michael J. AusserlechneriD· 2 shared Antonia DegeniD· 1 shared Daniela KaralliD· 1 shared Edward E. BrunneriD· 1 shared Elisabeth DamischiD· 1 shared Francesco BaschieriiD· 1 shared Francesco BonolloiD· 1 shared François TyckaertiD· 1 shared

Activity by Year

2025-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 31 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersMolecular Biology

Michael J. AusserlechnerORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Molecular BiologybioRxivPreprintSep 22, 2026

✦ In-depth digest

Naloxone as mitochondrial phenotype rescuer in a 3D bioprinted LCHADD/VLCADD model

Antonia Degen, Michael J. Ausserlechner, Verena Sturmlehner…·Judith Hagenbuchner

Naloxone, a NOX2 inhibitor, largely restored mitochondrial networks and curbed a pro-fibrotic signature in LCHADD/VLCADD patient fibroblasts, and rescued impaired vessel formation in 3D bioprinted vascularized constructs.

DOI 10.64898/2026.09.07.749837

humanbulk RNA-seq

𝕏 PostBluesky

Cancer BiologyJournal of Experimental & Clinical Cancer ResearchPeer-reviewedDec 1, 2025

Unraveling the YAP1-TGFβ1 axis: a key driver of androgen receptor loss in prostate cancer-associated fibroblasts

Edward E. Brunner, Elisabeth Damisch, Melanie Emma Groninger…·Natalie Sampson

This study identifies the YAP1-TGFβ1 axis as a driver of androgen receptor loss in prostate cancer-associated fibroblasts, showing its role in promoting aggressive disease and resistance to therapy.

3 citations

humanbulk RNA-seq

𝕏 PostBluesky